Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Jury is out in another case linking Novartis' Zometa to jawbone death
Fierce Pharma
Thursday, May 16, 2013 - 10:23am
tags:
Zometa, Novartis
Roche immunotherapy shows response over range of cancers
Reuters
Thursday, May 16, 2013 - 10:22am
tags:
Roche, immunotherapy, MPDL3280A, melanoma, lung cancer, kidney cancer
Johnson & Johnson, Medtronic Frontrunners In Race To Develop Artificial Pancreas
Seeking Alpha
Thursday, May 16, 2013 - 10:20am
tags:
JNJ, Medtronic, devices, artificial pancreas, type 1 diabetes
Zoetis' Apoquel for allergic dogs approved by FDA
The Fly on the Wall
Thursday, May 16, 2013 - 10:18am
tags:
FDA, animal health, Zoetis, Apoquel
Novartis says no intention of pursuing Actavis, Bloomberg reports
Yahoo/Fly on the Wall
Thursday, May 16, 2013 - 10:17am
tags:
Actavis, Novartis, M&A
Theravance Looks to Reward Shareholders by Splitting Into Two Distinct Companies
Motley Fool
Thursday, May 16, 2013 - 9:01am
tags:
Theravance
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thursday, May 16, 2013 - 8:54am
tags:
Gilead, ASCO, JNJ, Pharmacyclics, idelalisab, ibrutinib, CLL
The Ranbaxy Whistleblower And The Scheme To Fool The FDA
Pharmalot
Thursday, May 16, 2013 - 8:51am
tags:
whistleblower lawsuits, Ranbaxy, FDA
Why The Medicines Company May Be About to Take Off
Motley Fool
Thursday, May 16, 2013 - 8:50am
tags:
Medicines Company
Bristol-Myers Drug Cocktail Stymies Melanoma Tumors
Bloomberg
Thursday, May 16, 2013 - 8:49am
tags:
melanoma, Bristol-Myers Squibb, nivolumab, Yervoy
J&J Wins Expanded Approval of Simponi for Bowel Disease
Bloomberg
Wednesday, May 15, 2013 - 5:15pm
tags:
Simponi, JNJ, FDA, inflammatory bowel disease
Roche exploring sale of diabetes device unit
Yahoo/Reuters
Wednesday, May 15, 2013 - 5:14pm
tags:
Roche, devices, diabetes, blood glucose monitoring
New Data On Boston Scientific's Atrial Fibrillation Watchman Device Could Lift Outlook
Seeking Alpha
Wednesday, May 15, 2013 - 3:00pm
tags:
atrial fibrilation, WATCHMAN, devices, Boston Scientific
Contraceptive Ring: Another Under-The-Radar Catalyst For Antares
Seeking Alpha
Wednesday, May 15, 2013 - 2:58pm
tags:
Nestragel, Nestorone, contraceptives, contraceptive rings, Antares, devices
Bovie's J-Plasma May Slay The MRSA Dragon (And Other Nasties)
Seeking Alpha
Wednesday, May 15, 2013 - 2:54pm
tags:
J-plasma, MRSA, Bovie Medical, devices
Nektar Posts Wider Loss, Maintains View
Yahoo/Zacks
Wednesday, May 15, 2013 - 2:52pm
tags:
earnings, Nektar
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
Bloomberg
Wednesday, May 15, 2013 - 2:51pm
tags:
Bayer, Algeta, FDA, prostate cancer, Xofigo
5 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Wednesday, May 15, 2013 - 2:50pm
tags:
Gilead, Bristol-Myers Squibb, JNJ, Merck, Pfizer
Bristol-Myers Targets Heart-Failure Drugs in R&D Effort
Bloomberg
Wednesday, May 15, 2013 - 2:48pm
tags:
heart failure, Bristol-Myers Squibb, R&D
Actavis Said to Have Spurned $15 Billion Offer From Mylan
Bloomberg
Wednesday, May 15, 2013 - 10:44am
tags:
Actavis, M&A, Mylan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.